Berentsen S - Search Results

1

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.

Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Jäger U, et al. Among authors: berentsen s. Blood Rev. 2020 May;41:100648. doi: 10.1016/j.blre.2019.100648. Epub 2019 Dec 5. Blood Rev. 2020. PMID: 31839434 Review.

2

Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients.

Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, Ghanima W, Shammas FV, Tjønnfjord GE. Berentsen S, et al. Blood. 2004 Apr 15;103(8):2925-8. doi: 10.1182/blood-2003-10-3597. Epub 2003 Dec 30. Blood. 2004. PMID: 15070665 Free article. Clinical Trial.

3

Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.

Berentsen S. Berentsen S. Clin Lymphoma Myeloma. 2009 Mar;9(1):110-2. doi: 10.3816/CLM.2009.n.030. Clin Lymphoma Myeloma. 2009. PMID: 19362990 Review.

4

[Autoimmune hemolytic anemia].

Berentsen S, Sundic T, Hervig T, Tjønnfjord GE. Berentsen S, et al. Tidsskr Nor Laegeforen. 2009 Nov 5;129(21):2226-31. doi: 10.4045/tidsskr.09.0161. Tidsskr Nor Laegeforen. 2009. PMID: 19898570 Free article. Review. Norwegian.

5

High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.

Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, Jacobsen EM, Thoresen AS, Beiske K, Tjønnfjord GE. Berentsen S, et al. Blood. 2010 Oct 28;116(17):3180-4. doi: 10.1182/blood-2010-06-288647. Epub 2010 Jul 15. Blood. 2010. PMID: 20634373 Free article. Clinical Trial.

6

Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.

Berentsen S, Tjønnfjord GE. Berentsen S, et al. Blood Rev. 2012 May;26(3):107-15. doi: 10.1016/j.blre.2012.01.002. Epub 2012 Feb 12. Blood Rev. 2012. PMID: 22330255 Review.

7

Complement, cold agglutinins, and therapy.

Berentsen S. Berentsen S. Blood. 2014 Jun 26;123(26):4010-2. doi: 10.1182/blood-2014-04-568733. Blood. 2014. PMID: 24970929 Free article.

8

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.

Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA; RITP study group. Ghanima W, et al. Lancet. 2015 Apr 25;385(9978):1653-61. doi: 10.1016/S0140-6736(14)61495-1. Epub 2015 Feb 5. Lancet. 2015. PMID: 25662413 Clinical Trial.

9

Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Berentsen S, Sundic T. Berentsen S, et al. Biomed Res Int. 2015;2015:363278. doi: 10.1155/2015/363278. Epub 2015 Jan 29. Biomed Res Int. 2015. PMID: 25705656 Free PMC article. Review.

10

Cold agglutinin-mediated autoimmune hemolytic anemia.

Berentsen S, Randen U, Tjønnfjord GE. Berentsen S, et al. Hematol Oncol Clin North Am. 2015 Jun;29(3):455-71. doi: 10.1016/j.hoc.2015.01.002. Epub 2015 Mar 12. Hematol Oncol Clin North Am. 2015. PMID: 26043385 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters